Administration of low-dose epoetin-alpha facilitates adherence to ribavirin in triple therapy with pegylated interferon-alpha-2b and telaprevir
Author:
Affiliation:
1. Department of Gastroenterology and Hepatology; National Hospital Organization; Osaka National Hospital; Osaka Japan
Publisher
Wiley
Subject
Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12224/fullpdf
Reference15 articles.
1. The natural history of chronic hepatitis C virus infection;Seeff;Clin Liver Dis,1997
2. Editors of the Drafting Committee for Hepatitis Management Guidelines: The Japan Society of H. Guidelines for the Management of Hepatitis C Virus Infection: First edition, May 2012, The Japan Society of Hepatology;Hepatol Res,2013
3. Treatment of chronic hepatitis C virus genotype 1 with peginterferon, ribavirin, and epoetin alpha;Shiffman;Hepatology,2007
4. Use of epoetin beta during combination therapy of infection with hepatitis c virus with ribavirin improves a sustained viral response;Falasca;J Med Virol,2010
5. Epoetin alpha improves the response to antiviral treatment in HCV-related chronic hepatitis;Bertino;Eur J Clin Pharmacol,2010
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapy;BMC Infectious Diseases;2024-03-11
2. Association between inosine triphosphatase rs1127354 polymorphisms and ribavirin‐induced anaemia and outcome in hepatitis C virus‐infected patients: A meta‐analysis;Journal of Clinical Pharmacy and Therapeutics;2020-07-31
3. Ribavirin/telaprevir;Reactions Weekly;2017-10
4. Pharmacogenetics of ribavirin-induced anemia in HCV patients;Pharmacogenomics;2016-06
5. ITPA deficiency and ribavirin level are still predictive of anaemia in HCV–HIV-coinfected patients receiving ribavirin combined with a first-generation DAA (ANRS HC27 study);Antiviral therapy;2016
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3